Reported Earnings • May 01
First quarter 2026 earnings released: EPS: US$0.001 (vs US$0 in 1Q 2025) First quarter 2026 results: EPS: US$0.001 (up from US$0 in 1Q 2025). Revenue: US$32.4m (down 6.0% from 1Q 2025). Net income: US$1.91m (up US$2.93m from 1Q 2025). Profit margin: 5.9% (up from net loss in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. お知らせ • Apr 26
PT. Polychem Indonesia Tbk, Annual General Meeting, Jun 02, 2026 PT. Polychem Indonesia Tbk, Annual General Meeting, Jun 02, 2026. Reported Earnings • Mar 19
Full year 2025 earnings released: US$0.001 loss per share (vs US$0.003 loss in FY 2024) Full year 2025 results: US$0.001 loss per share (improved from US$0.003 loss in FY 2024). Revenue: US$144.7m (up 32% from FY 2024). Net loss: US$2.67m (loss narrowed 74% from FY 2024). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth. Reported Earnings • Nov 04
Third quarter 2025 earnings released: EPS: US$0 (vs US$0.001 loss in 3Q 2024) Third quarter 2025 results: EPS: US$0 (improved from US$0.001 loss in 3Q 2024). Revenue: US$38.7m (up 52% from 3Q 2024). Net income: US$1.06m (up US$3.17m from 3Q 2024). Profit margin: 2.7% (up from net loss in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Board Change • Oct 24
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Independent Commissioner Ilham Sumantri was the last independent director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. お知らせ • May 17
PT. Polychem Indonesia Tbk, Annual General Meeting, Jun 24, 2025 PT. Polychem Indonesia Tbk, Annual General Meeting, Jun 24, 2025. Reported Earnings • Nov 01
Third quarter 2024 earnings released: US$0.001 loss per share (vs US$0.001 loss in 3Q 2023) Third quarter 2024 results: US$0.001 loss per share (in line with 3Q 2023). Revenue: US$25.5m (up 25% from 3Q 2023). Net loss: US$2.10m (loss narrowed 14% from 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has fallen by 18% per year, which means it is performing significantly worse than earnings. New Risk • Aug 21
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indonesian stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.0% average weekly change). Market cap is less than US$100m (Rp556.2b market cap, or US$36.1m). Reported Earnings • Apr 04
Full year 2023 earnings released: US$0.005 loss per share (vs US$0.007 loss in FY 2022) Full year 2023 results: US$0.005 loss per share (improved from US$0.007 loss in FY 2022). Revenue: US$104.8m (down 27% from FY 2022). Net loss: US$19.1m (loss narrowed 28% from FY 2022). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. New Risk • Nov 04
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$8.9m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$8.9m free cash flow). Earnings have declined by 9.4% per year over the past 5 years. Minor Risk Market cap is less than US$100m (Rp571.7b market cap, or US$36.6m). Reported Earnings • Aug 08
Second quarter 2023 earnings released: EPS: US$0 (vs US$0.002 loss in 2Q 2022) Second quarter 2023 results: EPS: US$0 (improved from US$0.002 loss in 2Q 2022). Revenue: US$25.5m (down 41% from 2Q 2022). Net loss: US$718.8k (loss narrowed 91% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 15% per year. Board Change • Nov 16
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Independent Commissioner Bambang Husodo was the last independent director to join the board, commencing their role in 2009. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Jun 06
First quarter 2022 earnings released: US$0.001 loss per share (vs US$0 in 1Q 2021) First quarter 2022 results: US$0.001 loss per share (down from US$0 in 1Q 2021). Revenue: US$45.5m (down 7.1% from 1Q 2021). Net loss: US$5.21m (down US$6.11m from profit in 1Q 2021). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Reported Earnings • Apr 27
Full year 2021 earnings released: EPS: US$0 (vs US$0.01 loss in FY 2020) Full year 2021 results: EPS: US$0 (up from US$0.01 loss in FY 2020). Revenue: US$190.2m (up 25% from FY 2020). Net income: US$756.3k (up US$39.4m from FY 2020). Profit margin: 0.4% (up from net loss in FY 2020). Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has fallen by 14% per year, which means it is performing significantly worse than earnings. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 7 highly experienced directors. 1 independent director (3 non-independent directors). Independent Director Tarunkumar Pal was the last independent director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Jun 18
Full year 2020 earnings released: US$0.01 loss per share (vs US$0.008 loss in FY 2019) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: US$152.7m (down 35% from FY 2019). Net loss: US$38.7m (loss widened 31% from FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 64 percentage points per year, which is a significant difference in performance. Is New 90 Day High Low • Dec 21
New 90-day high: Rp178 The company is up 52% from its price of Rp117 on 23 September 2020. The Indonesian market is up 23% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 45% over the same period. Is New 90 Day High Low • Nov 05
New 90-day high: Rp150 The company is up 42% from its price of Rp106 on 07 August 2020. The Indonesian market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. Is New 90 Day High Low • Oct 07
New 90-day high: Rp133 The company is up 30% from its price of Rp102 on 09 July 2020. The Indonesian market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 4.0% over the same period.